CareFusion Alaris Recall Affects More than 145,000 Pumps
CareFusion 303, Inc. is recalling the Alaris Infusion Pump Module 8100 due to risk that the keys could become unresponsive or stuck, leading to an infusion delay or interruption. The Class I recall affects 145,492 devices in the United States that were manufactured between January 15, 2019 and December 5, 2019, and distributed between January 23, 2019 and December 5, 2019.
The infusion pump and vital signs monitoring system delivers fluids such as medications, blood or blood products into a patient’s body in a controlled way. The product issues can prevent clinicians from changing the fluid or medication infusions. Patients most in danger are high-risk patients who are receiving life-sustaining infusions, because delays or interruption of infusions can cause serious injury or death.
The FDA has received 79 complaints related to the device issue; no injuries or deaths have been reported. CareFusion sent a New Urgent Medical Device Recall letter to affected customers on March 3, instructing them to remove the pump from service if the keyboard shows signs of lifting, becomes unresponsive or stuck. They were instructed to continue infusion if administering a critical medication and to replace the PC unit once it is deemed safe.
Related Articles
-
The agency is urging manufacturers to not only have recall policies in place before a recall is necessary, but to also act quickly in initiating a recall when public health is at risk.
-
Beginning October 1, 2023, the FDA’s Total Product Life Cycle Advisory Program (TAP) Pilot will expand to include the Office of Neurological and Physical Medicine Devices (OHT5).
-
The center is proposing that Philips repair, replace or refund recalled devices manufactured after November 2015.
-
The acquisition expands Veranex’s footprint for product design engineering services across the U.S., with combined company offices now in the Eastern, Central, and Western regions
